The involvement of EGFR and MAPK signaling pathways in the development of precancerous changes, including the development of biliary intraepithelial neoplasia and the further development of OF-CCA, provides new insights into biological carcinogenesis and expands our understanding of anticancer therapies. The gene discussed is EGFR; the disease is cholangiocarcinoma.